Enter assignee name

Celmed Oncology (USA), Inc.

USPTO Granted Patents = 8

Forward Citations = 17

Loading Chart...

8 inventors (with patents filed for the assignee):

H Michael Shepard (6 out of 58 patents)

Venkata Ramana Doppalapudi (2 out of 42 patents)

Michael P Groziak (2 out of 6 patents)

4. Maria V Sergeeva (2 out of 3 patents)

5. Andrew Vaino (1 out of 7 patents)

6. Carlo Ballatore (1 out of 9 patents)

7. Danielle M Lehsten (1 out of 1 patent)

8. Ming Fai Chan (1 out of 39 patents)

8 patents: Sort by Forward Citations

1. 7605144 - Enzyme catalyzed therapeutic compounds (2009-10-20),

2. 7601703 - Enzyme catalyzed therapeutic agents (2009-10-13),

3. 7465734 - Methods and compositions for overcoming resistance to biologic and chemotherapy (2008-12-16),

4. 7462605 - Phosphoramidate compounds and methods of use (2008-12-09),

5. 7419968 - Methods for treating therapy-resistant tumors (2008-09-02),

6. 7163923 - Peptide deformylase activated prodrugs (2007-01-16),

7. 7138388 - Methods to treat autoimmune and inflammatory conditions (2006-11-21),

8. 7001922 - Peptide deformylase activated prodrugs (2006-02-21),

Celmed Oncology (USA), Inc. is a leading biopharmaceutical company focused on developing innovative cancer treatments. With a strong commitment to research and development, Celmed Oncology is dedicated to improving the lives of cancer patients through cutting-edge therapies. The company's mission is to advance the field of oncology and provide hope to those affected by cancer worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

8 Patents

#250 in

#1,810 in Canada